TOP STORIES

• ORGANIZATION Teshirogi, Nakayama to Lead Japan Pharma Lobbies for 1 More Year; Ex-MHLW Official Shiraishi to Join JPMA
  March 16, 2020

• BUSINESS Coronavirus Woes Stymie Drug Makers’ Sales Activities in Japan, Curbs on Doctor Visits Continue
  March 13, 2020

• COMMENTARY Lenvima Heading into Megablockbuster Territory, Will Merck Tie-Up Help It Top Combined Aricept/Pariet Sales?
  March 12, 2020

• BUSINESS Drug Makers Calling Off Welcoming Ceremonies for New Hires over Coronavirus
  March 11, 2020

• REGULATORY Japan Cabinet OKs Bill to Allow Govt to Declare Emergency over Coronavirus
  March 11, 2020

• BUSINESS Japan’s 2020 Price Revision Hits Major Drugs with Double-Digit Slashes: Top 5 Product Survey
  March 10, 2020

• BUSINESS Japan’s Big 3 Generic Makers See 12.2% Price Cut vs. FY2018: Jiho Poll
  March 9, 2020

• BUSINESS Chugai, Teijin Suffer Hefty 9% Cuts in 2020 Drug Price Revision: Jiho Poll
  March 6, 2020

• REGULATORY Xolair Faces 37.3% Price Slash, Keytruda 20.9% in April: MHLW
  March 5, 2020

• BUSINESS Sumitomo Dainippon Creates Chief Scientific Officer Post to Optimize Portfolio
  March 4, 2020

• BUSINESS Vital-Net to Create 20-Strong Team of “Regenerative Medicine Liaisons”
  March 3, 2020

• BUSINESS Xolair’s Re-Pricing Decided, but Regulators and Novartis Were at Odds over Patient Projections
  March 2, 2020

• BUSINESS MSD Japan Embarking on 2-Step Spinoff for Women’s Health, Legacy Brands
  February 28, 2020

• BUSINESS Japan Drug Makers Fearing Manufacturing Crisis as Coronavirus Spreads
  February 27, 2020

• REGULATORY Zolgensma Now in Line for Japan Approval in March, All Eyes Now Riveted on Price
  February 27, 2020

• BUSINESS Fujifilm Receives Avigan Supply Requests from Overseas amid Coronavirus Outbreak
  February 27, 2020

• BUSINESS Drug Makers in Japan Upping Coronavirus Measures; Takeda Switches to Online Interviews for New R&D Hires
  February 26, 2020

• REGULATORY Japan Approves Label Expansions for Rozlytrek, Alecensa and More
  February 25, 2020

• BUSINESS “Tender Process Needs to Be Improved” in Response to Bid-Rigging Scandal by Top 4 Wholesalers: Hospital Management Advisor
  February 25, 2020

• ORGANIZATION Japan Pharma Lobbies Likely to Retain Chiefs as Off-Year Re-Pricing Debate Looms
  February 21, 2020

ページ

• « 先頭
• ‹ Prev
• …
• 113
• 114
• 115
• 116
• 117
• 118
• 119
• 120
• 121
• …
• Next ›
• 最終 »